Travecta Therapeutics announces it has closed its oversubscribed Series A Round at $27 Million
[et_pb_section fb_built=”1″ _builder_version=”4.6.0″ hover_enabled=”0″ custom_padding=”||30px||false|false”... Read More
Home/
Latest Posts
Travecta Therapeutics Presents at Ventures Day Singapore in 2020, on February 7th
[et_pb_section fb_built=”1″ _builder_version=”4.6.0″ custom_margin=”||||false|false”... Read More
Travecta showcases its novel blood-brain barrier transport platform in New York, USA
[et_pb_section fb_built=”1″ _builder_version=”4.6.0″ custom_padding=”||30px||false|false”][et_pb_row... Read More
Travecta Therapeutics presents corporate updates at TKS 1 Investor Day in Singapore
[et_pb_section fb_built=”1″ _builder_version=”4.6.0″ custom_padding=”||30px||false|false”][et_pb_row... Read More
Tackling the blood-brain barrier: Duke-NUS discovery leads to startup Travecta
[et_pb_section fb_built=”1″ _builder_version=”4.6.0″ custom_padding=”||30px||false|false”][et_pb_row... Read More